.png)
.png)
.png)
Report Library
View More
Datamonitor Healthcare Trends & Mar...
August 20, 2019
Datamonitor Healthcare CV&Met: Chem...
August 19, 2019
Datamonitor Healthcare I&I: Heredit...
August 19, 2019
Datamonitor Healthcare CV&Met: Duch...
August 16, 2019
Datamonitor Healthcare Oncology: Ce...
August 16, 2019
Datamonitor Healthcare Oncology: Pa...
August 14, 2019
Datamonitor Healthcare Other: Erect...
August 14, 2019
Datamonitor Healthcare I&I: Hidrade...
August 13, 2019
Datamonitor Healthcare Infectious D...
August 13, 2019
Datamonitor Healthcare Other: Hypog...
August 8, 2019
Impact Events
More| Date | Lead Company |
Event | Type | Approval Change |
Approval Likelihood |
|---|---|---|---|---|---|
| 8/21/19 | AstraZeneca (AZN) | Imfinzi for Non-Small Cell Lung Cancer (NSCLC) | Subscribers Only | Subscribers Only | Subscribers Only |
| 8/20/19 | AstraZeneca (AZN) | Farxiga for Congestive Heart Failure (CHF) and Cardiomyopathies | Subscribers Only | Subscribers Only | Subscribers Only |
| 8/20/19 | NuCana (NCNA) | Acelarin for Pancreatic Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 8/19/19 | Sarepta (SRPT) | Vyondys 53 for Duchenne Muscular Dystrophy (DMD) | Subscribers Only | Subscribers Only | Subscribers Only |
| 8/19/19 | Redx Pharma (AIM: REDX) | RXC004 for Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range |
Lead Company |
Drug | Expected Catalyst |
|---|---|---|---|
| 12/31/18 | Subscribers Only | Subscribers Only | Trial Announcement - Initiation |
| 08/16/19 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |
| 08/24/19 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 08/27/19 | Subscribers Only | Subscribers Only | Regulatory - PDUFA/Approval Decision (US) |
| Now - 08/28/19 | Subscribers Only | Subscribers Only | Regulatory - Orphan Drug Designation (Europe) |
